Cargando…
Protein engineering approach to enhance activity assays of mono-ADP-ribosyltransferases through proximity
Human mono-ADP-ribosylating PARP enzymes have been linked to several clinically relevant processes and many of these PARPs have been suggested as potential drug targets. Despite recent advances in the field, efforts to discover inhibitors have been hindered by the lack of tools to rapidly screen for...
Autores principales: | Galera-Prat, Albert, Alaviuhkola, Juho, Alanen, Heli I, Lehtiö, Lari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574550/ https://www.ncbi.nlm.nih.gov/pubmed/36130221 http://dx.doi.org/10.1093/protein/gzac006 |
Ejemplares similares
-
Evaluation of 3‐ and 4‐Phenoxybenzamides as Selective Inhibitors of the Mono‐ADP‐Ribosyltransferase PARP10
por: Korn, Patricia, et al.
Publicado: (2021) -
Preparation of screening assays for ADP-ribosyl readers and erasers using the GAP-tag as a binding probe
por: Sowa, Sven T., et al.
Publicado: (2022) -
A molecular toolbox for ADP-ribosyl binding proteins
por: Sowa, Sven T., et al.
Publicado: (2021) -
Intracellular mono-ADP-ribosyltransferases at the host–virus interphase
por: Lüscher, Bernhard, et al.
Publicado: (2022) -
The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain
por: Sowa, Sven T., et al.
Publicado: (2022)